Partial effects of the protein kinase C inhibitor chelerythrine in a battery of tests for manic-like behavior in black Swiss mice

Pharmacological Reports

Volumn 66, Issue 4, 2014, Pages 722-725

  Einat, Haim ^a,b,c  

^a ACADEMIC COLLEGE OF TEL AVIV YAFFO   (Israel)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bipolar disorder; Black Swiss mice; Depression; Mania; Protein kinase C

Indexed keywords

AMPHETAMINE; CHELERYTHRINE; PROTEIN KINASE C; BENZOPHENANTHRIDINE DERIVATIVE; TRANQUILIZER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BIPOLAR DISORDER; CONTROLLED STUDY; DRUG EFFECT; ELEVATED PLUS MAZE TEST; EXPERIMENTAL BEHAVIORAL TEST; FORCED SWIM TEST; HYPERACTIVITY; MALE; MANIA; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; TASTE PREFERENCE; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; FOOD PREFERENCE; INTRAPERITONEAL DRUG ADMINISTRATION; MAZE TEST; MOTOR ACTIVITY; PSYCHOLOGY;

ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BENZOPHENANTHRIDINES; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD PREFERENCES; INJECTIONS, INTRAPERITONEAL; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; PROTEIN KINASE C;

EID: 84902491763     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2014.03.013     Document Type: Article

References (21)

1. C.A. Zarate, and H.K. Manji Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder CNS Drugs 23 7 2009 569 582
2. H. Einat, P. Yuan, S.T. Szabo, S. Dogra, and H.K. Manji Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder Neuropsychobiology 55 3-4 2007 123 131 (Pubitemid 47525230)
3. E. Abrial, A. Etievant, C. Betry, H. Scarna, G. Lucas, and N. Haddjeri et al. Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats Prog Neuropsychopharmacol Biol Psychiatry 2013 40 48
4. P. Sabioni, I.P. Baretta, E.M. Ninomiya, L. Gustafson, A.L. Rodrigues, and R. Andreatini The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs Prog Neuropsychopharmacol Biol Psychiatry 32 8 2008 1927 1931
5. A. Yildiz, S. Guleryuz, D.P. Ankerst, D. Ongur, and P.F. Renshaw Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen Arch Gen Psychiatry 65 3 2008 255 263 (Pubitemid 351342442)
6. J.M. Bebchuk, C.L. Arfken, S. Dolan-Manji, J. Murphy, K. Hasanat, and H.K. Manji A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania Arch Gen Psychiatry 57 1 2000 95 97 (Pubitemid 30035669)
7. C.A. Zarate Jr., J.B. Singh, P.J. Carlson, J. Quiroz, L. Jolkovsky, and D.A. Luckenbaugh et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study Bipolar Disord 9 6 2007 561 570 (Pubitemid 47365623)
8. L. Cervo, S. Mukherjee, A. Bertaglia, and R. Samanin Protein kinases A and C are involved in the mechanisms underlying consolidation of cocaine place conditioning Brain Res 775 1-2 1997 30 36 (Pubitemid 28020486)
9. N. Galeotti, and C. Ghelardini Antidepressant phenotype by inhibiting the phospholipase Cbeta(1) - protein kinase Cgamma pathway in the forced swim test Neuropharmacology 60 6 2011 937 943
10. A.B. Hains, M.A. Vu, P.K. Maciejewski, C.H. van Dyck, M. Gottron, and A.F. Arnsten Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress Proc Natl Acad Sci USA 106 42 2009 17957 17962
11. S. Flaisher-Grinberg, and H. Einat Strain Specific battery of tests for separate behavioral domains of mania Front Psychiatry 1 10 2010 1 10
12. C. Hannah-Poquette, G.W. Anderson, S. Flaisher-Grinberg, J. Wang, T.M. Meinerding, and H. Einat Modeling mania: further validation for black Swiss mice as model animals Behav Brain Res 223 1 2011 222 226
13. S. Flaisher-Grinberg, N. Kronfeld-Schor, and H. Einat Models of mania: from facets to domains and from animal models to model animals J Psychopharmacol 24 3 2010 437 438
14. S. Flaisher-Grinberg, and H. Einat Mice models for the manic pole of bipolar disorder T.D. Gould, Mice models for mood and anxiety disorders 2009 Springer Press Berlin 297 326
15. M. Kalinichev, and L.A. Dawson Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK-3) inhibitors in a strain specific model of acute mania Int J Neuropsychopharmacol 6 2011 1 17
16. T.D. Gould, K.C. O'Donnell, A.M. Picchini, and H.K. Manji Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium Neuropsychopharmacology 32 6 2007 1321 1333 (Pubitemid 46788857)
17. J.N. Crawley Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests Brain Res 835 1 1999 18 26 (Pubitemid 29336546)
18. K.M. Hiscock, J.A. Linde, and H. Einat Black Swiss mice as a new animal model for mania: a preliminary study J Med Biol Sci 1 2 2007 1 6
19. S. Flaisher-Grinberg, S. Overgaard, and H. Einat Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania J Neurosci Methods 177 1 2009 44 50
20. S. Flaisher-Grinberg, and H. Einat A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior J Pharmacol Toxicol Methods 59 3 2009 141 145
21. S. Flaisher-Grinberg, and H. Einat Amphetamine-induced conditioned place preference test and modeling domains of bipolar disorder Open J Neuropsychopharmacol 4 2011 18 24